During the past decade, Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 10 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Allergan" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada" are "Gastroparesis" (3 trials), "Cardiovascular Disease" (2 trials), "Diabetes Mellitus" (2 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Obesity" (2 trials). Many other conditions were trialed in "Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada" in a lesser frequency.

Most popular intervention types in "Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada" are "Drug" (15 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Tirzepatide" (3 trials), "Relamorelin" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".